Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Changes in Fatigue and Cognition in Patients with Relapsing Forms of Multiple Sclerosis Treated with Natalizumab: The ENER-G Study.
The impact of multiple sclerosis on family members: a review of the literature.
Multiple cutaneous necrotic lesions associated with Interferon beta-1b injection for multiple sclerosis treatment: A case report and literature review.
Fulminant Central Plus Peripheral Nervous System Demyelination without Antibodies to Neurofascin.
Glycoengineering of Interferon-β 1a Improves Its Biophysical and Pharmacokinetic Properties.
The VZV/IE63-specific T cell response prevents herpes zoster in fingolimod-treated patients.
[Functional MRI during the execution of a motor task in patients with multiple sclerosis and fatigue.]
Cognitive rehabilitation correlates with the functional connectivity of the anterior cingulate cortex in patients with multiple sclerosis.
Multiple Sclerosis in Children.
1st International Symposium on Gait and Balance in MS: Gait and Balance Measures in the Evaluation of People with MS.
Protective effect of tanreqing injection on axon myelin damage in the brain of mouse model for experimental autoimmune encephalomyelitis.
Pregnancy in multiple sclerosis: a questionnaire study.
Assessing upper limb function in multiple sclerosis.
Characterizing contrast-enhancing and re-enhancing lesions in multiple sclerosis.
Complement activation in multiple sclerosis plaques: an immunohistochemical analysis.
2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission--I. Anticonvulsant properties.
Major stressful life events in adulthood and risk of multiple sclerosis.
Using biomarkers to predict progression from clinically isolated syndrome to multiple sclerosis.
17β-trenbolone, an anabolic-androgenic steroid as well as an environmental hormone, contributes to neurodegeneration.
Associations of alcohol consumption with clinical and MRI measures in multiple sclerosis.
Comparison of DNA-Hydrolyzing Antibodies from the Cerebrospinal Fluid and Serum of Patients with Multiple Sclerosis.
Effects of the Anti-Multiple Sclerosis Immunomodulator Laquinimod on Anxiety and Depression in Rodent Behavioral Models.
Comprehensive Immunophenotyping of Cerebrospinal Fluid Cells in Patients with Neuroimmunological Diseases.
Fingolimod to treat severe multiple sclerosis after natalizumab-associated progressive multifocal leukoencephalopathy: a valid option?
T cell vaccination benefits relapsing progressive multiple sclerosis patients: a randomized, double-blind clinical trial.

Pages